Najat Khan

President and CEO, Recursion

Salt Lake City, Utah

About

Najat Khan is the President and Chief Executive Officer of Recursion Pharmaceuticals, a clinical-stage company in Salt Lake City, Utah that uses artificial intelligence in drug discovery and development. Recursion’s 2026 proxy statement says she has held the chief executive and president roles since January 2026 and has served on the board since April 2024. She signed the company’s quarterly report filed on November 2, 2026.

Khan holds a Ph.D. in organic chemistry with a focus on computational chemistry from the University of Pennsylvania and a B.S. in computational chemistry from Colgate University. She worked at The Boston Consulting Group from 2011 to 2018, ending as a partner in its healthcare practice, and then held several roles at Johnson and Johnson, including Chief Data Science Officer. At Recursion she was Chief Research and Development Officer and Chief Commercial Officer from July 2024 to December 2025. Whoo also has pages for Stéphane Bancel of Moderna and Eric Lefkofsky of Tempus.

Whoo compiled this page from public sources: Recursion proxy statement 2026, Recursion Form 10-Q, September 2026, Recursion Q3 2026 results release. It is not affiliated with or endorsed by Najat Khan. Are you Najat Khan? Claim this page, or write to [email protected] to correct or remove it. Last updated: 2026-11-18.

Want a page like this? Create yours from your résumé.

Experience

Chief Executive Officer and President — Recursion


January 2026 – Present | Salt Lake City, Utah

  • Board member since April 2024

  • Chief Research and Development Officer and Chief Commercial Officer, July 2024 to December 2025
  • Chief Data Science Officer and Senior Vice President, Strategy and Portfolio Organization, R&D — Johnson and Johnson


    June 2023 – June 2024

  • Earlier Johnson and Johnson roles from March 2018 included Head of R&D Strategic Initiatives and Chief Operating Officer, R&D Data Science

  • Co-chair of the Johnson and Johnson Data Science Council from February 2020 to June 2024
  • Partner, Healthcare Practice — The Boston Consulting Group


    August 2011 – February 2018

  • Progressed through roles of increasing seniority, ending as partner

Education

PhD in Organic Chemistry (Computational Chemistry) — University of Pennsylvania

BS in Computational Chemistry, minor in Economics/Business — Colgate University

Projects